Utama › Tumor Neuroendokrin › Virginia
Kajian klinikal Tumor Neuroendokrin di Virginia
7 kajian untuk Tumor Neuroendokrin sedang mencari peserta di lokasi di Virginia.
Bandar di Virginia
Teks kajian rasmi (Bahasa Inggeris)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Virginia, Charlottesville
- Virginia Cancer Specialists - Fairfax Office, Fairfax
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06943755Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- University of Virginia Comprehensive Cancer Center, Charlottesville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07087054Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Research Facility, Charlottesville
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07165132Project: Every Child for Younger Patients With Cancer
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- dan 3 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Charlottesville
- Crinetics Study Site, Fairfax
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07129252Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Virginia Cancer Specialists, Fairfax
Mengambil pesertaFasa 1/2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 14 Mei 2026 · NCT05636618SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.